𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients

✍ Scribed by Peter Nygren; Kenneth Hande; Kevin J. Petty; Margaret Fedgchin; Kristien van Dyck; Anup Majumdar; Debbie Panebianco; Marina de Smet; Tuli Ahmed; M. Gail Murphy; Keith M. Gottesdiener; Veronique Cocquyt; Simon van Belle

Publisher
Springer
Year
2005
Tongue
English
Weight
251 KB
Volume
55
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Lack of effect of cisplatin on i. v. L-P
Lack of effect of cisplatin on i. v. L-PAM plasma pharmacokinetics in ovarian cancer patients
✍ M. Zucchetti; M. D'Incalci; Y. Willems; F. Cavalli; C. Sessa πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 268 KB

Melphalan (L-PAM) pharmacokinetics were investigated in nine ovarian cancer patients before and after cisplatin (DDP) treatment. When L-PAM was given 24 h before DDP, the elimination half-life (t 1/2 beta), plasma clearance (Clp), and volume of distribution (Vd beta) of L-PAM were, respectively: 46.

Moclobemide pharmacokinetics in depresse
Moclobemide pharmacokinetics in depressed patients: Lack of age effect
✍ K. Maguire; A. Pereira; J. Tiller πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 364 KB

## Abstract The pharmacokinetics of moclobemide were examined in 19 depressed patients following a single oral dose of 50 mg. Ten patients were aged >60 years and nine <59 years. Plasma concentrations were analysed by gas chromatography with nitrogen‐specific detection. Pharmacokinetic parameters c